Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Obefazimod

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abivax Unveils Obefazimod's Anti-Fibrotic Activity In IBD
    Abivax Unveils Obefazimod's Anti-Fibrotic Activity In IBD

    21 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/21/3242210/0/en/Abivax-Presents-First-Evidence-of-Anti-Fibrotic-Activity-for-Obefazimod-Alongside-New-Clinical-Efficacy-and-Safety-Analyses-in-Inflammatory-Bowel-Disease-at-ECCO-2026.html

    GLOBENEWSWIRE
    21 Feb 2026
    Share Share
    Abivax Provides 2026 Corporate Outlook
    Abivax Provides 2026 Corporate Outlook

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214893/0/en/Abivax-Provides-2026-Corporate-Outlook.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Abivax to Present 22 Obefazimod Abstracts in IBD at ECCO 2026
    Abivax to Present 22 Obefazimod Abstracts in IBD at ECCO 2026

    17 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/17/3207315/0/en/Abivax-Announces-Acceptance-of-22-Abstracts-Evaluating-Obefazimod-in-Inflammatory-Bowel-Disease-at-ECCO-2026-Featuring-an-Oral-Presentation-on-Preclinical-Anti-Fibrotic-Findings.html

    GLOBENEWSWIRE
    17 Dec 2025
    Share Share
    Abivax Ph3 Obefazimod Data Show QoL Gains in Ulcerative Colitis
    Abivax Ph3 Obefazimod Data Show QoL Gains in Ulcerative Colitis

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179780/0/en/Abivax-Announces-Patient-Reported-Outcomes-Data-from-the-Phase-3-ABTECT-Induction-Trials-of-Obefazimod-Demonstrating-Significant-Improvements-in-Quality-of-Life-for-Patients-with-M.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Abivax Presents 8-Week ABTECT Data From Late-Breaking Session
    Abivax Presents 8-Week ABTECT Data From Late-Breaking Session

    06 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/06/3161446/0/en/Abivax-Announces-Late-Breaking-Presentation-of-8-Week-ABTECT-Induction-Trial-Results-in-Participants-With-and-Without-Prior-Inadequate-Response-to-Advanced-Therapies.html

    GLOBENEWSWIRE
    06 Oct 2025
    Share Share
    Abivax Presents 8-Week ABTECT Trial Results With Safety Update
    Abivax Presents 8-Week ABTECT Trial Results With Safety Update

    05 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/05/3161328/0/en/Abivax-Announces-Late-Breaking-Presentation-of-8-Week-ABTECT-Trial-Results-with-Updated-Safety-Data.html

    GLOBENEWSWIRE
    05 Oct 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.